Stocktoria
NEONC TECHNOLOGIES HOLDINGS, INC. NTHI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-03-26
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Revenue | $39,990 | $83,000 |
| Operating income | -$58.2M | -$7.1M |
| Net income | -$62.1M | -$11.9M |
| Operating cash flow | -$20.4M | -$4.2M |
| Total assets | $2.8M | $3.4M |
| Total liabilities | $20.3M | $8.9M |
| Shareholders' equity | -$17.5M | -$5.5M |
| Ratios | ||
| Operating margin | -145637.5% | -8605.4% |
| Net margin | -155404.4% | -14335.5% |
| Return on assets | -2200.9% | -348.2% |
| Return on equity | 355.0% | 216.1% |
| Current ratio | 0.07 | 0.25 |
| Revenue growth | -51.8% | — |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001979414 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.